Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,064.01
(
-0.63%
)
US TECH 100
25,946.80
(
0.67%
)
Dow Jones
49,149.38
(
-0.60%
)
Brent Oil
95.30
(
0.31%
)
Bitcoin
78,039.79
(
2.24%
)
News Focus
News Focus
Post# of 300
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

MahinAgency

Send PM Follow Ignore
Followers 29
Posts 617
Boards Moderated 0
Alias Born 08/25/2023

MahinAgency

Re: Sirpeter post# 167

Wednesday, 11/06/2024 2:52:30 PM

Wednesday, November 06, 2024 2:52:30 PM

Post# of 300
NASDAQ: $CRDL
 Cardiol Therapeutics recently reported encouraging outcomes from its Phase II MAvERIC trial of CardiolRx, an ultra-pure oral cannabidiol formulation for recurrent pericarditis.

The 12-month price target is $10
Bullish
Bullish
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CRDL News
More CRDL News